We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
Cap. Flow
+$861M
Cap. Flow %
2.55%
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 14.29%
2 Financials 14.18%
3 Technology 13.8%
4 Industrials 10.4%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGI
2676
DELISTED
Silicon Graphics Intl.
SGI
$228K ﹤0.01%
45,422
+10,363
+30% +$57.5K
EBTC
2677
DELISTED
Enterprise Bancorp
EBTC
$227K ﹤0.01%
9,471
-2,695
-22% -$64.6K
NUTR
2678
DELISTED
Nutraceutical International Co
NUTR
$227K ﹤0.01%
9,823
-2,720
-22% -$64.7K
DTLK
2679
DELISTED
Datalink Corp
DTLK
$227K ﹤0.01%
30,232
+16
+0.1% +$133
BBBY
2680
Bed Bath & Beyond
BBBY
$481M
$226K ﹤0.01%
18,638
+925
+5% +$11K
KTOS icon
2681
Kratos Defense & Security Solutions
KTOS
$8.74B
$226K ﹤0.01%
55,102
-17,593
-24% -$79.5K
NJ
2682
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$226K ﹤0.01%
12,038
-474
-4% -$8.17K
ARA
2683
DELISTED
American Renal Associates Holdings, Inc
ARA
$225K ﹤0.01%
+7,775
New +$216K
PRMW
2684
DELISTED
Primo Water Corporation
PRMW
$225K ﹤0.01%
+19,084
New +$212K
NVIV
2685
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$223K ﹤0.01%
2
+1
+100% +$118K
HSKA
2686
DELISTED
Heska Corp
HSKA
$222K ﹤0.01%
+5,966
New +$201K
WK icon
2687
Workiva
WK
$3.36B
$221K ﹤0.01%
+16,147
New +$205K
SRGA
2688
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$221K ﹤0.01%
2,054
RENX
2689
DELISTED
RELX N.V.
RENX
$221K ﹤0.01%
12,686
MEET
2690
DELISTED
The Meet Group, Inc. Common Stock
MEET
$220K ﹤0.01%
+41,354
New +$153K
ODC icon
2691
Oil-Dri
ODC
$1.44B
$219K ﹤0.01%
12,698
-3,294
-21% -$54.9K
OXFD
2692
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$218K ﹤0.01%
24,180
+5,850
+32% +$57.3K
GLBL
2693
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$218K ﹤0.01%
66,923
+15,253
+30% +$41.7K
HEOP
2694
DELISTED
Heritage Oaks Bancorp
HEOP
$218K ﹤0.01%
27,437
-8,895
-24% -$71K
LJPC
2695
DELISTED
La Jolla Pharmaceutical Company
LJPC
$218K ﹤0.01%
13,595
-707
-5% -$12.7K
CRIS icon
2696
Curis
CRIS
$9.78M
$217K ﹤0.01%
69
+14
+25% +$50K
ARDX icon
2697
Ardelyx
ARDX
$1.22B
$216K ﹤0.01%
24,739
+5,053
+26% +$41.3K
FMX icon
2698
Fomento Económico Mexicano
FMX
$43.6B
$216K ﹤0.01%
2,332
+13
+0.6% +$1.19K
BATRA icon
2699
Atlanta Braves Holdings Series A
BATRA
$3.49B
$215K ﹤0.01%
+14,272
New +$219K
NIC icon
2700
Nicolet Bankshares
NIC
$3.6B
$215K ﹤0.01%
+5,648
New +$217K

Similar funds

RhumbLine Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
  • RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
  • RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
  • RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
  • RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.

Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.